Evidence map›Paper›PMID 23733768›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Underuse of hospice care by Medicaid-insured patients with stage IV lung cancer in New York and California.

Jennifer W Mack, Kun Chen, Francis P Boscoe, Foster C Gesten, Patrick J Roohan, Jane C Weeks, Maria J Schymura, Deborah Schrag

Abstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2015
    Guideline
  5. Article
  6. Article
  7. Effect of the COVID-19 Pandemic on Place of Death Among Medicaid and Commercially Insured Patients With Cancer in Washington State.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Updated Overview of the SEER-Medicare Data: Enhanced Content and Applications.Journal of the National Cancer Institute. Monographs · 2020
    Review
  15. Article
  16. Review
  17. Palliative Care in Lung Cancer: When to Start.Current oncology reports · 2018
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jennifer W MackDana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. Jennifer_mack@dfci.harvard.edu
Kun Chen
Francis P Boscoe
Foster C Gesten
Patrick J Roohan
Jane C Weeks
Maria J Schymura
Deborah Schrag

Funding

Building CER Capacity: Aligning CRN, CMS, and State Resources to Map Cancer CareRC2CA148185 · NCI · DANA-FARBER CANCER INST · PI RITZWOLLER, DEBRA P, WEEKS, JANE C. · 2009 to 2009
$2.0M
Cancer Care Delivery in MedicaidR01CA131847 · NCI · DANA-FARBER CANCER INST · PI SCHRAG, DEBORAH · 2008 to 2012
$1.8M
Partnerships Between Medicaid, Tumor Registries & Cancer Control ResearchersK05CA169384 · NCI · DANA-FARBER CANCER INST · PI SCHRAG, DEBORAH · 2012 to 2016
$586k
NCI NIH HHS K05 CA169384NCI NIH HHS R01 CA131847NCI NIH HHS R01CA131847NCI NIH HHS RC2 CA148185NCI NIH HHS RC2CA148185-01
6 · The paper itself

Abstract

purposeMedicare patients with advanced cancer have low rates of hospice use. We sought to evaluate hospice use among patients in Medicaid, which insures younger and indigent patients, relative to those in Medicare. PATIENTS AND

methodsUsing linked patient-level data from California (CA) and New York (NY) state cancer registries, state Medicaid programs, NY Medicare, and CA Surveillance, Epidemiology, and End Results-Medicare data, we identified 4,797 CA Medicaid patients and 4,001 NY Medicaid patients ages 21 to 64 years, as well as 27,416 CA Medicare patients and 16,496 NY Medicare patients ages ≥ 65 years who were diagnosed with stage IV lung cancer between 2002 and 2006. We evaluated hospice use, timing of enrollment, and location of death (inpatient hospice; long-term care facility or skilled nursing facility; acute care facility; home with hospice; or home without hospice). We used multiple logistic regressions to evaluate clinical and sociodemographic factors associated with hospice use.

resultsAlthough 53% (CA) and 44% (NY) of Medicare patients ages ≥ 65 years used hospice, fewer than one third of Medicaid-insured patients ages 21 to 64 years enrolled in hospice after a diagnosis of stage IV lung cancer (CA, 32%; NY, 24%). A minority of Medicaid patient deaths (CA, 19%; NY, 14%) occurred at home with hospice. Most Medicaid patient deaths were either in acute-care facilities (CA, 28%; NY, 36%) or at home without hospice (CA, 39%; NY, 41%). Patient race/ethnicity was not associated with hospice use among Medicaid patients.

conclusionGiven low rates of hospice use among Medicaid enrollees and considerable evidence of suffering at the end of life, opportunities to improve palliative care delivery should be prioritized.

Indexed as

AdultAge FactorsCaliforniaCause of DeathCohort StudiesFemaleHealthcare DisparitiesHospice CareHumansLong-Term CareLung NeoplasmsMaleMedicaidMedicareMiddle AgedMultivariate Analysis

Identifiers

PMID23733768
PMCPMC3699723

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.